Evidence map›Paper›PMID 37386003›Full record

ReviewInternational journal of oral science2023

Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation.

Paola Dongiovanni, Marica Meroni, Sara Casati, Riccardo Goldoni, Douglas Vieira Thomaz, Nermin Seda Kehr, Daniela Galimberti, Massimo Del Fabbro, Gianluca M Tartaglia

Registry-linked trialAbstract readReview
In one paragraph

Review in International journal of oral science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07217951 (Assessing the Feasibility of Multi-modal Biosensing for Monitoring Mobility and Cognition in Older Adults), which is not on this map. Cited by 97 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07217951 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Assessing the Feasibility of Multi-modal Biosensing for Monitoring Mobility and Cognition in Older Adults

TypeobservationalSponsorTufts UniversityRan2025 to 2028Enrolled20ConditionsChronic Stress, Systemic Inflammation, Mobility and IndependenceArmsEutectogel Sensors and Microneedle Patches
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Best practices for using biological data in psychological research.Journal of mood and anxiety disorders · 2026
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paola Dongiovanni *Medicine and Metabolic Diseases, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0003-4343-7213
Marica Meroni *Medicine and Metabolic Diseases, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Sara CasatiDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy. sara.casati@unimi.it.ORCID 0000-0002-5049-7321
Riccardo GoldoniDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, Milan, Italy.
Douglas Vieira ThomazLaboratory of Medicinal Pharmaceutical Chemistry, Faculty of Pharmacy, Federal University of Goiás, Goiânia, GO, Brazil.ORCID 0000-0003-0000-3466
Nermin Seda KehrDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Daniela GalimbertiDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.ORCID 0000-0002-9284-5953
Massimo Del FabbroDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.ORCID 0000-0001-7144-0984
Gianluca M TartagliaDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several chronic disorders including type 2 diabetes (T2D), obesity, heart disease and cancer are preceded by a state of chronic low-grade inflammation. Biomarkers for the early assessment of chronic disorders encompass acute phase proteins (APP), cytokines and chemokines, pro-inflammatory enzymes, lipids and oxidative stress mediators. These substances enter saliva through the blood flow and, in some cases, there is a close relation between their salivary and serum concentration. Saliva can be easily collected and stored with non-invasive and cost-saving procedures, and it is emerging the concept to use it for the detection of inflammatory biomarkers. To this purpose, the present review aims to discuss the advantages and challenges of using standard and cutting-edge techniques to discover salivary biomarkers which may be used in diagnosis/therapy of several chronic diseases with inflammatory consequences with the pursuit to possibly replace conventional paths with detectable soluble mediators in saliva. Specifically, the review describes the procedures used for saliva collection, the standard approaches for the measurement of salivary biomarkers and the novel methodological strategies such as biosensors to improve the quality of care for chronically affected patients.

Indexed as

Diabetes Mellitus, Type 2BiomarkersCytokinesHumansInflammationOxidative StressBiomarkersCytokines

Identifiers

PMID37386003
PMCPMC10310701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.